Rapt Therapeutics, Inc.2024财年实现净利润-1.30亿美元，同比减少11.11%

市场透视03-10

3月10日，Rapt Therapeutics, Inc.（RAPT.US）公布财报，公告显示公司2024财年净利润为-1.30亿美元，同比减少11.11%；其中营业收入为0.00美元，每股基本收益为-3.19美元。从资产负债表来看，Rapt Therapeutics, Inc.（RAPT.US）总负债50.42百万美元，其中短期债务2.42百万美元，资产负债比为0.05，流动比率为0.05。机构...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2518281156?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2025-03-10 00:01","share_image_url":"https://static.laohu8.com/9a95c1376e76363c1401fee7d3717173","id":"2518281156","market":"us","top_or_hot":-1,"title":"Rapt Therapeutics, Inc.2024财年实现净利润-1.30亿美元，同比减少11.11%","media":"市场透视","content":"<div>\n<p>3月10日，Rapt Therapeutics, Inc.（RAPT.US）公布财报，公告显示公司2024财年净利润为-1.30亿美元，同比减少11.11%；其中营业收入为0.00美元，每股基本收益为-3.19美元。从资产负债表来看，Rapt Therapeutics, Inc.（RAPT.US）总负债50.42百万美元，其中短期债务2.42百万美元，资产负债比为0.05，流动比率为0.05。机构...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310000223a2689865&s=b\">网页链接</a>\n\n</div>\n","source":"tencent","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Rapt Therapeutics, Inc.2024财年实现净利润-1.30亿美元，同比减少11.11%</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nRapt Therapeutics, Inc.2024财年实现净利润-1.30亿美元，同比减少11.11%\n</h2>\n\n<h4 class=\"meta\">\n\n\n2025-03-10 00:01 北京时间&nbsp;&nbsp;&nbsp;<a href=http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310000223a2689865&s=b><strong>市场透视</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>3月10日，Rapt Therapeutics, Inc.（RAPT.US）公布财报，公告显示公司2024财年净利润为-1.30亿美元，同比减少11.11%；其中营业收入为0.00美元，每股基本收益为-3.19美元。从资产负债表来看，Rapt Therapeutics, Inc.（RAPT.US）总负债50.42百万美元，其中短期债务2.42百万美元，资产负债比为0.05，流动比率为0.05。机构...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310000223a2689865&s=b\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"RAPT","symbol_name":"RAPT Therapeutics, Inc.","start_time":0,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310000223a2689865&s=b","article_id":"2518281156","we_media_id":null,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310000223a2689865&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2518281156","pubTimestamp":1741536074,"columns":[],"sourceInfo":{"source_id":"tencent","name":"腾讯"},"weMediaInfo":null,"summary":"3月10日，Rapt Therapeutics, Inc.公布财报，公告显示公司2024财年净利润为-1.30亿美元，同比减少11.11%；其中营业收入为0.00美元，每股基本收益为-3.19美元。从资产负债表来看，Rapt Therapeutics, Inc.总负债50.42百万美元，其中短期债务2.42百万美元，资产负债比为0.05，流动比率为0.05。机构评级：截至2025年3月10日，当前有3家机构对Rapt Therapeutics, Inc.目标价做出预测，其中目标均价为6.00美元，其中最低目标价为2.00美元，最高目标价为10.00美元。","collect":0,"end_time":0,"defaultTopTitle":"qq.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"RAPT":"RAPT Therapeutics, Inc.","LENZ":"Therapeutics"},"translate_title":"Rapt Therapeutics, Inc. achieved net income of-$130 million in fiscal 2024, a decrease of 11.11% year-over-year","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"RAPT":0.6,"LENZ":0.6},"content_text":"3月10日，Rapt Therapeutics, Inc.（RAPT.US）公布财报，公告显示公司2024财年净利润为-1.30亿美元，同比减少11.11%；其中营业收入为0.00美元，每股基本收益为-3.19美元。从资产负债表来看，Rapt Therapeutics, Inc.（RAPT.US）总负债50.42百万美元，其中短期债务2.42百万美元，资产负债比为0.05，流动比率为0.05。机构评级：截至2025年3月10日，当前有3家机构对Rapt Therapeutics, Inc.目标价做出预测，其中目标均价为6.00美元，其中最低目标价为2.00美元，最高目标价为10.00美元。公司简介：RAPT Therapeutics Inc 是一家基于临床阶段的免疫学生物制药公司。它专注于发现、开发和商业化口服小分子疗法用于未满足需求的肿瘤和炎症疾病患者。该公司的管道产品包括FLX475，旨在选择性地抑制免疫抑制调节性T细胞向肿瘤的迁移;RPT193，旨在选择性地抑制2型T辅助细胞向炎症组织的迁移。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。）","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-1","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.35.11","shortVersion":"4.35.11","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2518281156","isCrawlerRequest":true}